Arrowhead to Present at RBC Capital Markets’ Global Healthcare Conference

[Business Wire] – Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced that President and CEO, Christopher Anzalone, Ph.D., will present at the 2014 RBC Capital Markets’ Global Healthcare Con more

View todays social media effects on ARWR

View the latest stocks trending across Twitter. Click to view dashboard

See who Arrowhead is hiring next, click here to view